Convalescent Plasma for Immunocompromised Patients
Current Topics in Microbiology and Immunology · 2024
DOI: 10.1007/82_2024_272 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Topics in Microbiology and Immunology, 2024. Verfasst von Shmuel Shoham. Beteiligte Einrichtung: Department of Medicine, Johns Hopkins School of Medicine, 1830 East Monument St., Room 447, Baltimore, MD, 21205, USA. sshoham1@jhmi.edu. Hauptthemen laut MEDLINE: Immunocompromised Host, COVID-19, SARS-CoV-2. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
COVID-19 convalescent plasma (CCP) is an important therapeutic option for immunocompromised patients with COVID-19. Such patients are at increased risk for serious complications of infection and may also develop a unique syndrome of persistent infection. This article reviews the rationale for CCP utilization in immunocompromised patients and the evidence for its value in immunosuppressed patients with both acute and persistent COVID-19. Both historical precedence and understanding of the mechanisms of action of antibody treatment support this use, as do several lines of evidence derived from case series, comparative studies, randomized trials, and systematic reviews of the literature. A summary of recommendations from multiple practice guidelines is also provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Johns Hopkins School of Medicine, 1830 East Monument St., Room 447, Baltimore, MD, 21205, USA. sshoham1@jhmi.edu.
Zitieren
APA
Shoham, S. (2024). Convalescent Plasma for Immunocompromised Patients. Current Topics in Microbiology and Immunology. https://doi.org/10.1007/82_2024_272
Vancouver
Shoham S. Convalescent Plasma for Immunocompromised Patients. Current Topics in Microbiology and Immunology. 2024. doi:10.1007/82_2024_272
BibTeX
@article{Shoham2024,
author = {Shoham, Shmuel},
title = {Convalescent Plasma for Immunocompromised Patients},
journal = {Current Topics in Microbiology and Immunology},
year = {2024},
doi = {10.1007/82_2024_272}
}
EUVIMED